Influence of aminoguanidine and the endothelin antagonist, SE 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats

British Journal of Pharmacology

Volumn 118, Issue 7, 1996, Pages 1822-1828

  Gardiner, S M ^a   Kemp, P A ^a   March, J E ^a   Bennett, T ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aminoguanidine; Angiotensin II; Endothelin; Lipopolysaccharide; SB 209670; Vasopressin

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; AMINOGUANIDINE; ANGIOTENSIN; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; LIPOPOLYSACCHARIDE; LOSARTAN; NITRIC OXIDE SYNTHASE; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CONDUCTANCE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME INHIBITION; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HYPOTENSION; KIDNEY BLOOD VESSEL; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD VESSEL; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; TACHYCARDIA; VASOCONSTRICTION; VASODILATATION;

EID: 0029945296     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15609.x     Document Type: Article

References (37)

1. BATIN, P., GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1991). Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats. Life Sci., 48, 733-739.
2. CORBETT, J.A., TILTON, R.G., CHANG, K., HASAN, K.S., IDO, Y., WANG, J.L., SWEETLAND, M.A., LANCASTER JR, J.R., WILLIAMSON, J.R. & MCDANIEL, M.L. (1992). Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes, 41, 552-556.
3. DOUGLAS, S.A., EDWARDS, R.M., ELLIOTT, J.D. & OHLSTEIN, E.H. (1995a). In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670. Br. J. Pharmacol., 114, 405-413.
4. DOUGLAS, S.A., GELLAI, M., EZEKIEL, M., FEUERSTEIN, G.Z., ELLIOTT, J.D. & OHLSTEIN, E.H. (1995b). Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670. Hypertension, 25, 818-822.
5. GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1989). Regional haemodynamic changes following hypovolemia in conscious rats. Am. J. Physiol., 256, R1076-R1083.
6. GARDINER, S.M., COMPTON, A.M., BENNETT, T., PALMER, R.M.J. & MONCADA, S. (1990a). Control of regional blood flow by endothelium-derived nitric oxide. Hypertension, 15, 486-492.
7. G-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br. J. Pharmacol., 101, 625-631.
8. G-nitro-L-arginine methyl ester. Br. J. Pharmacol., 101, 632-639.
9. GARDINER, S.M., KEMP, P.A. & BENNETT, T. (1993). Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats. Br. J. Pharmacol., 109, 222-228.
10. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1995a). Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670. Br. J. Pharmacol., 116, 1718-1719.
11. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1995b). Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol., 116, 2005-2016.
12. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1996). Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats. Br. J. Pharmacol., (in press).
13. GRIFFITHS, M.J.D., MESSENT, M., CURZEN, N.P. & EVANS, T.W. (1995). Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase. Am. J. Resp. Crit. Care Med., 152, 1599-1604.
14. GRIFFITHS, M.J.D., MESSENT, M., MACALLISTER, R.J. & EVANS, T.W. (1993). Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol., 110, 963-968.
15. HAYWOOD, J.R., SHAFFER, R.A., FASTENOW, C., FINK, G.D. & BRODY, M.J. (1981). Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am. J. Physiol., 241, H273-H278.
16. G-nitro-L-arginine and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem. Biophys. Res. Commun., 199, 147-154.
17. KUJUBU, D.A. & HERSCHMAN, H.R. (1992). Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem., 267, 7991-7994.
18. KUMARI, K., UMAR, S., BANSAL, V. & SAHIB, M.K. (1991). Inhibition of diabetes-associated complications by nucleophilic compounds. Diabetes, 40, 1079-1084.
19. LASZLO, F., EVANS, S.M. & WHITTLE, B.J.R. (1995). Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculaturc in vivo. Eur. J. Pharmacol., 272, 169-175.
20. LOPEZ-BELMONTE, J. & WHITTLE, B.J.R. (1995). Aminoguanidine-provoked leukocyte adherence to rat mcsenteric venules: role of constitutive nitric oxide synthase inhibition. Br. J. Pharmacol., 116, 2710-2714.
21. MISKO, T.P., MOORE, W.M., KASTEN, T.P., NICKOLS, G.A., CORBETT, J.A., TILTON, R.G., MCDANIEL, M.L., WILLIAMSON, J.R. & CURRIE, M.G. (1993). Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol., 233, 119-125.
22. NAKANE, M., KLINGHOFER, V., KUK, J.E., DONNELLY, J.L., BUDZIK, G.P., POLLOCK, J.S., BASHA, F. & CARTER, G.W. (1995). Novel potent and selective inhibitors of inducible nitric oxide synthase. Mol. Pharmacol., 47, 831-834.
23. OHLSTEIN, E.H., NAMBI, P., DOUGLAS, S.A., EDWARDS, R.M., GELLAI, M., LAGO, A., LEBER, J.D., COUSINS, R.D., GAO, A., FRAZEE, J.S., PEISHOFF, C.E., BEAN, J.W., EGGLESTON, D.S., ELSHOURBAGY, N.A., KUMAR, C., LEE, J.A., YUE, T-L., LOUDEN, C., BROOKS, D.P., WEINSTOCK, J., FEUERSTEIN, G., POSTE, G., RUFFOLO, R.R., GLEASON, J.G. & ELLIOTT, J.D. (1994). SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 8052-8056.
24. OHRUI, T., YAMAUCHI, K., SEZIKAWA, K., OHKAWARA, Y., MAEYAMA, K., SASAKI, M., TAKEMURA, M., WADA, H., WATANABE, T., SASAKI, II. & TAKISHIMA, T. (1992). Histamine N-methyl-transferase controls the contractile response of guinea pig trachea to histamine. J. Pharmacol. Exp. Ther., 261, 1268-1272.
25. OU, P. & WOLFF, S.P. (1993). Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem. Pharmacol., 46, 1139-1144.
26. PAYA, D., GRAY, G.A., FLEMING, I. & STOCLET, J-C. (1993). Effect of dexamethasone on the onset and persistence of vascular hyporeactivity induced by E. coli lipopolysaccharide in rats. Circ. Shock, 41, 103-112.
27. RUBANYI, G.M. & POLOKOFF, M.A. (1994). Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology, Pharmacol. Rev., 46, 325-415.
28. SEILER, N., BOLKENIUS, F.N. & KNODGEN, B. (1985). The influence of catabolic reactions on polyamine excretion. Biochem. J., 225, 219-226.
29. SOUTHAN, G.J., SZABÓ, C. & THIEMERMANN. C. (1995). Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br. J. Pharmacol., 114, 510-516.
30. SUGIURA, M., INAGAMI, T. & KON, V. ( 1989). Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun., 161, 1220-1227.
31. SZABO, C., MITCHELL, J.A., THIEMERMANN, C. & VANE, J.R (1993). Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol., 108, 786-792.
32. VEMULAPALLI, S., CHIU, P.J.S., RIVELLI, M., FOSTER, C.J. & SYBERTZ, E.J. (1991). Modulation of circulating endothelin levels in hypertension and endotoxaemia in rats. J. Cardiovasc. Pharmacol., 18, 895-903.
33. WALLER, J., GARDINER, S.M. & BENNETT, T. (1994a). Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats. Br. J. Pharmacol., 112, 1057-1064.
34. WALLER, J., GARDINER, S.M. & BENNETT, T. (1994b). The effect of aminoguanidine on the regional haemodynamic changes during a continuous low infusion of lipopolysaccharide in conscious rats. Br. J. Pharmacol., 113, 6P.
35. WALLER, J., GARDINER, S.M. & BENNETT, T. (1995). Aminoguanidine does not diminish lipopolysaccharide-induced vascular hyporesponsiveness to acetylcholine or methoxamine in conscious rats. Br. J. Pharmacol., 114, 27P.
36. WU, C-C., CHEN, S-J., SZABÓ, C., THIEMERMANN, C. & VANE, J.R. (1995a). Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol., 114, 1666-1672.
37. WU, C-C., CROXTALL, J.D., PERRETTI, M., BRYANT, C.E., THIEMERMANN, C., FLOWER, R.J. & VANE, J.R. (1995b). Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc. Natl. Acad. Sci. U.S.A., 92, 3473-3477.